Dopamine Hypothesis - The Classic Pathway

- Core idea: Schizophrenia symptoms are caused by dysregulated dopamine activity in specific brain circuits.
- This hypothesis primarily explains the positive symptoms of schizophrenia.
⭐ The D2 receptor subtype is the main target of typical antipsychotic drugs, which act as antagonists.
📌 Mnemonic: MeLoDramatic (Mesolimbic) for positive symptoms; MeCoN (Mesocortical) for negative symptoms.
Glutamate Hypothesis - NMDA's Downfall
- Core Idea: Schizophrenia arises from hypofunction of NMDA glutamate receptors, particularly in the prefrontal cortex (PFC).
- Pharmacological Evidence: NMDA antagonists like PCP and ketamine induce both positive and negative symptoms.
- Pathway:
- ↓ NMDA activity on GABA interneurons disinhibits cortical glutamate neurons.
- This leads to downstream dopamine dysregulation:
- Mesocortical Pathway: ↓ Dopamine → Negative symptoms.
- Mesolimbic Pathway: ↑ Dopamine → Positive symptoms.
⭐ Exam Favorite: Psychosis induced by NMDA antagonists like PCP or ketamine supports the glutamate hypothesis, as they mimic both positive and negative symptoms of schizophrenia.

Serotonin & GABA - The Supporting Cast
-
Serotonin (5-HT) Hypothesis:
- Atypical antipsychotics (e.g., clozapine, risperidone) are potent 5-HT₂A receptor antagonists.
- This action is thought to ↑ dopamine release in the prefrontal cortex, potentially alleviating negative symptoms.
- Psychotomimetics like LSD are 5-HT₂A agonists, supporting this link.
-
GABAergic Dysfunction:
- Reduced function of GABAergic interneurons, particularly in the prefrontal cortex (PFC).
- Leads to disinhibition of pyramidal neurons, causing cortical noise and cognitive deficits.
- Post-mortem studies show ↓ GABA-producing enzymes (GAD₆₇).
⭐ The efficacy of atypical antipsychotics is tied to their high 5-HT₂A to D₂ receptor blockade ratio, improving negative symptoms and reducing extrapyramidal side effects.
Neuroanatomy - A Shrinking Story
- Ventricular Enlargement:
- ↑ size of lateral and third ventricles is a common finding.
- This enlargement is a proxy for surrounding brain tissue loss (atrophy).
- Cortical & Subcortical Atrophy:
- Generalized ↓ in gray matter volume, especially in the temporal lobe (hippocampus, amygdala) and frontal lobe.
- Results in widened cortical sulci.
- ↓ thalamic volume, particularly the dorsomedial nucleus.
⭐ Exam Favorite: The hippocampus shows cellular disarray; pyramidal cells are disorganized rather than neatly arranged, contributing to dysfunctional information processing.
High‑Yield Points - ⚡ Biggest Takeaways
- Positive symptoms are linked to excess dopamine in the mesolimbic pathway.
- Negative symptoms are associated with dopamine hypoactivity in the mesocortical pathway.
- Antipsychotic-induced EPS result from dopamine blockade in the nigrostriatal pathway.
- Hyperprolactinemia is caused by dopamine blockade in the tuberoinfundibular pathway.
- The glutamate hypothesis suggests that NMDA receptor hypofunction also contributes to schizophrenia.
- Common structural brain changes include enlarged cerebral ventricles and cortical atrophy.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app